Improving the quality of the cannabis debate: Defining the different domains

British Medical Journal

Volumn 320, Issue 7227, 2000, Pages 108-110

  Strang, John ^a   Witton, John ^a   Hall, Wayne ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

CAR DRIVING; DRUG ABUSE; DRUG DEPENDENCE; GLAUCOMA; HEALTH CARE POLICY; HUMAN; MENTAL DISEASE; MULTIPLE SCLEROSIS; NAUSEA; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034620302     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7227.108     Document Type: Short Survey

References (42)

1. Ramsay M. Spiller J. Drug misuse declared in 1996: latest results from the British crime survey. London: Home Office, 1997.
2. British Medical Association. The misuse of drugs. London: Harwood Academic, 1997.
3. Robson P. Cannabis as medicine: time for the phoenix to rise? BMJ 1998;316:1034-5.
4. Hall W. The recent Australian debate about the prohibition on cannabis use. Addiction 1997;92:1109-15.
5. Russell MAH, Stapleton JA, Feyerabend C. Nicotine boost per cigarette as the controlling factor of intake regulation by smokers. In: Clarke PBS, Quik M, Adlkofer F, Thurau K, eds. Effects of nicotine on biological systems II. Basle: Birkhäuser, 1995:233-8.
6. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana and/or tobacco. Chest 1997;112:319-26.
7. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin D. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998;157:928-37.
8. Hall W. The respiratory risks of cannabis smoking. Addiction 1998;93: 1461-3.
9. Schneider U, Leweke FM, Mueller-Vahl KR, Emrich HM. Cannabinoid/ anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry 1998;2:110-3.
10. Hall W. Cannabis use and psychosis. Alcohol Rev 1998;17:433-44.
11. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996;42:201-7.
12. Mathers DC, Ghodse AH. Cannabis and psychotic illness. Br J Psychiatry 1992;161:648-53.
13. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;11:1483-6.
14. Allebeck P, Adamsson C, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm county. Acta Psychiatr Scand 1993;88:21-4.
15. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-9.
16. Negrete JC, Knapp WP, Douglas D, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 1986;16:515-20.
17. DeQuardo JR, Carpenter CF, Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res 1994;28:267-75.
18. Kovasznay B, Fleishcer J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 1997;23:195-201.
19. Swift W, Hall W, Didcott P, Reilly D. Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction 1998;93:1149-60.
20. Swift W, Copeland J, Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998;93:1681-92.
21. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the national comorbidity study. Clin Exp Psychopharmacol 1994;2:244-68.
22. Hall W, Solowij N, Lemon J. The health and psychological effects of cannabis use. Canberra: Australian Government Publication Service, 1994. (National drug strategy monograph series No 25.)
23. Stephens RS, Roffman RA, Simpson EE. Adult marijuana users seeking treatment. J Consult Clin Psychol 1993;61:1100-4.
24. Stephens RS, Rolfman RA, Simpson EE. Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychol 1994;62:92-9.
25. Reuter P, MacCoun R. Weighing the harms of cannabis use and cannabis prohibition. In: Proceedings of the international cannabis and psychosis conference. Melbourne: Department of Human Studies, 1999.
26. Kandel DB, Davies M. Progression to regular marijuana involvement: phenomenology and risk factors for near daily use. In: Glanz M, Pickens R, eds. Vulnerability to drug abuse. Washington: American Psychological Association, 1992.
27. Fergusson D, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997;92:279-96.
28. House of Lords Select Committee on Science and Technology. Cannabis: the scientific and medical evidence. London: Stationery Office, 1998.
29. Joy J, Watson S, Benson J, eds. Marijuana and medicine: assessing the sciencce base. Washington, DC: National Academy Press, 1999.
30. Abrams DI. Medical marijuana: tribulations and trials. J Pychoactive Drugs 1998;30:163-9.
31. Chesher G. Cannabis and road safety: an outline of the research studies to examine the effects of cannabis on driving skills and actual driving performance. In: The effects of drugs (other than alcohol) on road safety. Melbourne: Government Printer, 1995:67-96.
32. Albery I, Gossop M, Strang J. Illicit drugs and driving: a review of epidemiological, behavioural and psychological correlates. J Substance Misuse 1998;3:140-9.
33. Tomaszewski C, Kirk M, Bingham E, Saltzman B, Cook R, Kulig K. Urine toxicology screens in drivers suspected of driving while impaired from drugs. J Clini Toxicol 1996;34:37-44.
34. Soderstrom CA, Dischinger PC, Kerns TJ, Trilillis AL. Marijuana and other drug use among automobile and motorcycle drivers treated at a trauma center. Accident Anat Prev 1995;27:131-5.
35. Consensus Development Panel. Consensus report; drug concentrations and driving impairment. JAMA 1985;254:2618-21.
36. Single F. The impact of marijuana decriminalization: an update. J Public Health Policy 1989;10:456-66.
37. Donnelly N, Hall W, Christie P. The effects of partial decriminalisation on cannabis use in South Australia, 1985 to 1993. Aust J Public Health 1995;19:281-7.
38. Reuband K-H. Drug use and drug policy in western Europe: epidemiological findings in a comparative perspective. Eur Addict Res 1995;1:32-41.
39. MacCoun R, Reuter P. Interpreting Dutch cannabis policy: reasoning by analogy in the legalisation debate. Science 1997;278:47-52.
40. Johnston LD, O'Malley PM, Bachman JG. National survey results on drug use from the monitoring the future study 1975-1997. Rockville, MD: National Institute on Drug Abuse, 1998.
41. Home Office. Drug seizure and offender statistics, UK, 1997. London: Home Office, 1999.
42. Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998;352:1611-6.